Indoxyl Sulfate Promotes Proliferation of Human Aortic Smooth Muscle Cells by Inducing Oxidative Stress

被引:73
作者
Muteliefu, Gulinuer
Enomoto, Atsushi [2 ]
Niwa, Toshimitsu [1 ]
机构
[1] Nagoya Univ Hosp, Dept Clin Prevent Med, Showa Ku, Nagoya, Aichi 4668560, Japan
[2] Nagoya Univ, Inst Adv Res, Nagoya, Aichi 4648601, Japan
关键词
PROTEIN METABOLITE HYPOTHESIS; CHRONIC-RENAL-FAILURE; ORAL ADSORBENT; UREMIC RATS; CARDIOVASCULAR-DISEASE; GLOMERULAR SCLEROSIS; CONTROLLED-TRIAL; PROGRESSION; EXPRESSION; ACCUMULATION;
D O I
10.1053/j.jrn.2008.10.014
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 [营养与食品卫生学];
摘要
Objectives: Cardiovascular disease is a major cause of mortality in chronic kidney disease patients. We have recently demonstrated that indoxyl sulfate (IS), a uremic toxin, induced aortic calcification and aortic wall thickening in hypertensive rats. This study aimed to determine if IS promotes proliferation of human aortic smooth muscle cells (HASMCs) and if antioxidants inhibit the IS-induced cell proliferation. Methods: We examined the effect of IS at different concentration from 50 to 500 mu mol/L on cell proliferation of HASMCs by using 4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate (WST-1) assay. Further, the effect of antioxidants such as vitamin E, vitamin C, and N-acetylcysteine on the IS-induced proliferation of HASMCs was determined. Results: IS significantly promoted the proliferation of HASMCs concentration-dependently. The antioxidants significantly inhibited the IS-induced proliferation of HASMCs. Conclusion: IS promotes proliferation of HASMCs by inducing oxidative stress. (C) 2009 by the National Kidney Foundation, Inc. All rights reserved.
引用
收藏
页码:29 / 32
页数:4
相关论文
共 27 条
[1]
Indoxyl sulphate promotes aortic calcification with expression of osteoblast-specific proteins in hypertensive rats [J].
Adijiang, Ayinuer ;
Goto, Sumie ;
Uramoto, Satsuki ;
Nishijima, Fuyuhiko ;
Niwa, Toshimitsu .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (06) :1892-1901
[2]
Combination therapy with benazepril and oral adsorbent ameliorates progressive renal fibrosis in uremic rats [J].
Aoyama, I ;
Shimokata, K ;
Niwa, T .
NEPHRON, 2002, 90 (03) :297-312
[3]
Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial [J].
Boaz, M ;
Smetana, S ;
Weinstein, T ;
Matas, Z ;
Gafter, U ;
Iaina, A ;
Knecht, A ;
Weissgarten, Y ;
Brunner, D ;
Fainaru, M ;
Green, MS .
LANCET, 2000, 356 (9237) :1213-1218
[4]
Vascular calcifications in uremia: Old concepts and new insights [J].
Derici, U ;
El Nahas, AM .
SEMINARS IN DIALYSIS, 2006, 19 (01) :60-68
[5]
The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells [J].
Dou, L. ;
Jourde-Chiche, N. ;
Faure, V. ;
Cerini, C. ;
Berland, Y. ;
Dignat-George, F. ;
Brunet, P. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (06) :1302-1308
[6]
The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair [J].
Dou, L ;
Bertrand, E ;
Cerini, C ;
Faure, V ;
Sampol, J ;
Vanholder, R ;
Berland, Y ;
Brunet, P .
KIDNEY INTERNATIONAL, 2004, 65 (02) :442-451
[7]
Role of organic anion transporters in the tubular transport of indoxyl sulfate and the induction of its nephrotoxicity [J].
Enomoto, A ;
Takeda, M ;
Tojo, A ;
Sekine, T ;
Cha, SH ;
Khamdang, S ;
Takayama, F ;
Aoyama, I ;
Nakamura, S ;
Endou, H ;
Niwa, T .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (07) :1711-1720
[8]
Clinical epidemiology of cardiovascular disease in chronic renal disease [J].
Foley, RN ;
Parfrey, PS ;
Sarnak, MJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (05) :S112-S119
[9]
Indoxyl sulfate induces complex redox alterations in mesangial cells [J].
Gelasco, AK ;
Raymond, JR .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2006, 290 (06) :F1551-F1558
[10]
Superfocusing of terahertz waves [J].
Johnston, Michael B. .
NATURE PHOTONICS, 2007, 1 (01) :14-15